

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 9.62687388 |
| 2 | actin-mediated cell contraction (GO:0070252) | 8.83793177 |
| 3 | skeletal muscle contraction (GO:0003009) | 8.78484849 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 8.47195781 |
| 5 | creatine metabolic process (GO:0006600) | 7.90851753 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 7.29238273 |
| 7 | myofibril assembly (GO:0030239) | 6.95050471 |
| 8 | striated muscle contraction (GO:0006941) | 6.94528069 |
| 9 | actin filament-based movement (GO:0030048) | 6.55386796 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.52424106 |
| 11 | sarcomere organization (GO:0045214) | 6.39451336 |
| 12 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.38683309 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 6.07073124 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.07073124 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 5.90901554 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.90901554 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.83746191 |
| 18 | response to muscle activity (GO:0014850) | 5.82911852 |
| 19 | cardiac muscle contraction (GO:0060048) | 5.71021646 |
| 20 | cardiac myofibril assembly (GO:0055003) | 5.55944439 |
| 21 | response to inactivity (GO:0014854) | 5.55552574 |
| 22 | lysine catabolic process (GO:0006554) | 5.45673504 |
| 23 | lysine metabolic process (GO:0006553) | 5.45673504 |
| 24 | glycogen catabolic process (GO:0005980) | 5.42886330 |
| 25 | skeletal muscle adaptation (GO:0043501) | 5.39272603 |
| 26 | skeletal muscle fiber development (GO:0048741) | 5.36935452 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 5.33906389 |
| 28 | glucan catabolic process (GO:0009251) | 5.11528431 |
| 29 | glyoxylate metabolic process (GO:0046487) | 5.08291568 |
| 30 | kynurenine metabolic process (GO:0070189) | 5.07685843 |
| 31 | muscle contraction (GO:0006936) | 5.05732968 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.88914251 |
| 33 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.88799746 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 4.85872526 |
| 35 | myotube cell development (GO:0014904) | 4.85099089 |
| 36 | cellular polysaccharide catabolic process (GO:0044247) | 4.84928546 |
| 37 | fatty acid transmembrane transport (GO:1902001) | 4.83826479 |
| 38 | fatty acid beta-oxidation (GO:0006635) | 4.83799896 |
| 39 | carnitine shuttle (GO:0006853) | 4.83173525 |
| 40 | regulation of actin filament-based movement (GO:1903115) | 4.81330678 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 4.80909491 |
| 42 | glucan biosynthetic process (GO:0009250) | 4.79883568 |
| 43 | glycogen biosynthetic process (GO:0005978) | 4.79883568 |
| 44 | 2-oxoglutarate metabolic process (GO:0006103) | 4.78642237 |
| 45 | indole-containing compound catabolic process (GO:0042436) | 4.76026206 |
| 46 | indolalkylamine catabolic process (GO:0046218) | 4.76026206 |
| 47 | tryptophan catabolic process (GO:0006569) | 4.76026206 |
| 48 | actomyosin structure organization (GO:0031032) | 4.71109757 |
| 49 | bile acid biosynthetic process (GO:0006699) | 4.69422221 |
| 50 | cellular ketone body metabolic process (GO:0046950) | 4.69163227 |
| 51 | striated muscle hypertrophy (GO:0014897) | 4.64937414 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 4.63753854 |
| 53 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.63063020 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 4.57047839 |
| 55 | muscle system process (GO:0003012) | 4.56543357 |
| 56 | aspartate family amino acid catabolic process (GO:0009068) | 4.48710192 |
| 57 | acetyl-CoA metabolic process (GO:0006084) | 4.47554589 |
| 58 | cysteine metabolic process (GO:0006534) | 4.47206727 |
| 59 | tryptophan metabolic process (GO:0006568) | 4.46008093 |
| 60 | fatty acid oxidation (GO:0019395) | 4.45959171 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 4.45168308 |
| 62 | fatty acid catabolic process (GO:0009062) | 4.41805723 |
| 63 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.39504139 |
| 64 | sulfur amino acid catabolic process (GO:0000098) | 4.39367524 |
| 65 | polysaccharide catabolic process (GO:0000272) | 4.37983143 |
| 66 | regulation of cell communication by electrical coupling (GO:0010649) | 4.37529111 |
| 67 | lipid oxidation (GO:0034440) | 4.37074400 |
| 68 | muscle hypertrophy (GO:0014896) | 4.33084585 |
| 69 | striated muscle adaptation (GO:0014888) | 4.32735397 |
| 70 | tricarboxylic acid cycle (GO:0006099) | 4.28734470 |
| 71 | regulation of sequestering of triglyceride (GO:0010889) | 4.22986465 |
| 72 | urea metabolic process (GO:0019627) | 4.22194134 |
| 73 | urea cycle (GO:0000050) | 4.22194134 |
| 74 | serine family amino acid catabolic process (GO:0009071) | 4.22092416 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.18495104 |
| 76 | monocarboxylic acid catabolic process (GO:0072329) | 4.17829052 |
| 77 | valine metabolic process (GO:0006573) | 4.14421094 |
| 78 | branched-chain amino acid catabolic process (GO:0009083) | 4.14100055 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 4.12463777 |
| 80 | ketone body metabolic process (GO:1902224) | 4.07805824 |
| 81 | ethanol oxidation (GO:0006069) | 4.07271126 |
| 82 | complement activation, alternative pathway (GO:0006957) | 4.05697157 |
| 83 | muscle fiber development (GO:0048747) | 4.01444189 |
| 84 | negative regulation of fibrinolysis (GO:0051918) | 4.00933407 |
| 85 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00695920 |
| 86 | carnitine metabolic process (GO:0009437) | 3.98836377 |
| 87 | homocysteine metabolic process (GO:0050667) | 3.95566860 |
| 88 | nitrogen cycle metabolic process (GO:0071941) | 3.93597553 |
| 89 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.93373403 |
| 90 | protein carboxylation (GO:0018214) | 3.93373403 |
| 91 | biotin metabolic process (GO:0006768) | 3.93221188 |
| 92 | gluconeogenesis (GO:0006094) | 3.93072811 |
| 93 | glycogen metabolic process (GO:0005977) | 3.92574081 |
| 94 | cellular amino acid catabolic process (GO:0009063) | 3.89410669 |
| 95 | regulation of protein activation cascade (GO:2000257) | 3.89235979 |
| 96 | triglyceride homeostasis (GO:0070328) | 3.88996968 |
| 97 | acylglycerol homeostasis (GO:0055090) | 3.88996968 |
| 98 | bile acid metabolic process (GO:0008206) | 3.88743980 |
| 99 | coenzyme catabolic process (GO:0009109) | 3.88376459 |
| 100 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.87583276 |
| 101 | plasma membrane repair (GO:0001778) | 3.87459231 |
| 102 | fructose metabolic process (GO:0006000) | 3.87383327 |
| 103 | aromatic amino acid family metabolic process (GO:0009072) | 3.87311360 |
| 104 | regulation of fibrinolysis (GO:0051917) | 3.87112823 |
| 105 | branched-chain amino acid metabolic process (GO:0009081) | 3.86118578 |
| 106 | skeletal muscle tissue development (GO:0007519) | 3.85716797 |
| 107 | cellular glucan metabolic process (GO:0006073) | 3.85149284 |
| 108 | glucan metabolic process (GO:0044042) | 3.85149284 |
| 109 | regulation of fatty acid oxidation (GO:0046320) | 3.81689209 |
| 110 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.81605138 |
| 111 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.81191471 |
| 112 | organic acid catabolic process (GO:0016054) | 3.80841628 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.80841628 |
| 114 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76880246 |
| 115 | carnitine transmembrane transport (GO:1902603) | 3.73195609 |
| 116 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.72623434 |
| 117 | muscle tissue morphogenesis (GO:0060415) | 3.70300965 |
| 118 | succinate metabolic process (GO:0006105) | 3.67867272 |
| 119 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.67551581 |
| 120 | regulation of striated muscle contraction (GO:0006942) | 3.66664743 |
| 121 | tyrosine metabolic process (GO:0006570) | 3.65347487 |
| 122 | skeletal muscle tissue regeneration (GO:0043403) | 3.64205630 |
| 123 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.64087868 |
| 124 | regulation of complement activation (GO:0030449) | 3.63752067 |
| 125 | NADH metabolic process (GO:0006734) | 3.63419304 |
| 126 | positive regulation of fatty acid oxidation (GO:0046321) | 3.63242555 |
| 127 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.63160820 |
| 128 | amino-acid betaine transport (GO:0015838) | 3.61907478 |
| 129 | carnitine transport (GO:0015879) | 3.61907478 |
| 130 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.60898394 |
| 131 | plasma lipoprotein particle clearance (GO:0034381) | 3.60797216 |
| 132 | positive regulation of myotube differentiation (GO:0010831) | 3.60723597 |
| 133 | tricarboxylic acid metabolic process (GO:0072350) | 3.60248137 |
| 134 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.59887856 |
| 135 | muscle hypertrophy in response to stress (GO:0003299) | 3.59887856 |
| 136 | cardiac muscle adaptation (GO:0014887) | 3.59887856 |
| 137 | glutamate metabolic process (GO:0006536) | 3.57950893 |
| 138 | muscle adaptation (GO:0043500) | 3.57372551 |
| 139 | positive regulation of lipid catabolic process (GO:0050996) | 3.56683903 |
| 140 | hexose biosynthetic process (GO:0019319) | 3.56409929 |
| 141 | adult heart development (GO:0007512) | 3.55067625 |
| 142 | cellular modified amino acid catabolic process (GO:0042219) | 3.54839998 |
| 143 | striated muscle atrophy (GO:0014891) | 3.52791258 |
| 144 | regulation of cholesterol esterification (GO:0010872) | 3.50065415 |
| 145 | protein-lipid complex remodeling (GO:0034368) | 3.48555685 |
| 146 | macromolecular complex remodeling (GO:0034367) | 3.48555685 |
| 147 | plasma lipoprotein particle remodeling (GO:0034369) | 3.48555685 |
| 148 | phospholipid homeostasis (GO:0055091) | 3.47492516 |
| 149 | oxaloacetate metabolic process (GO:0006107) | 3.47120491 |
| 150 | reverse cholesterol transport (GO:0043691) | 3.44416856 |
| 151 | glycine metabolic process (GO:0006544) | 3.44144961 |
| 152 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.43348343 |
| 153 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.43348343 |
| 154 | muscle cell fate commitment (GO:0042693) | 3.40735082 |
| 155 | muscle cell cellular homeostasis (GO:0046716) | 3.38513000 |
| 156 | cellular response to epinephrine stimulus (GO:0071872) | 3.36568472 |
| 157 | response to epinephrine (GO:0071871) | 3.35575011 |
| 158 | benzene-containing compound metabolic process (GO:0042537) | 3.35216176 |
| 159 | response to activity (GO:0014823) | 3.33683702 |
| 160 | cellular glucuronidation (GO:0052695) | 3.30560068 |
| 161 | indolalkylamine metabolic process (GO:0006586) | 3.30382347 |
| 162 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.28191527 |
| 163 | serine family amino acid metabolic process (GO:0009069) | 3.28057929 |
| 164 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.27076829 |
| 165 | regulation of cholesterol metabolic process (GO:0090181) | 3.26487046 |
| 166 | phospholipid efflux (GO:0033700) | 3.26210239 |
| 167 | imidazole-containing compound metabolic process (GO:0052803) | 3.25548821 |
| 168 | negative regulation of lipase activity (GO:0060192) | 3.24735115 |
| 169 | negative regulation of cholesterol transport (GO:0032375) | 3.24714578 |
| 170 | regulation of the force of heart contraction (GO:0002026) | 3.21402955 |
| 171 | monosaccharide biosynthetic process (GO:0046364) | 3.21047169 |
| 172 | striated muscle cell development (GO:0055002) | 3.20427640 |
| 173 | positive regulation of cation channel activity (GO:2001259) | 3.19545208 |
| 174 | cellular carbohydrate catabolic process (GO:0044275) | 3.18979559 |
| 175 | negative regulation of necroptotic process (GO:0060546) | 3.17650020 |
| 176 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.15836117 |
| 177 | cardiac muscle cell development (GO:0055013) | 3.13991724 |
| 178 | muscle organ development (GO:0007517) | 3.11532551 |
| 179 | muscle structure development (GO:0061061) | 3.11246579 |
| 180 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.11230266 |
| 181 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.11230266 |
| 182 | muscle organ morphogenesis (GO:0048644) | 3.07487623 |
| 183 | muscle atrophy (GO:0014889) | 3.07379338 |
| 184 | fatty acid homeostasis (GO:0055089) | 3.06034382 |
| 185 | response to mercury ion (GO:0046689) | 2.99699356 |
| 186 | negative regulation of muscle contraction (GO:0045932) | 2.98605222 |
| 187 | actin-myosin filament sliding (GO:0033275) | 10.9796617 |
| 188 | muscle filament sliding (GO:0030049) | 10.9796617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.30554478 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.03491473 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.20254831 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.53862283 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.02957134 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.58179071 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.75430908 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.70523211 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.63880215 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.68732423 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.35214727 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.30494938 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.29467451 |
| 14 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04863233 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.0981514 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.88893153 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.83584517 |
| 18 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.72272514 |
| 19 | P68_20966046_ChIP-Seq_HELA_Human | 1.69841675 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.68353108 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.68056641 |
| 22 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.66652482 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.65592018 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.60203826 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.58396664 |
| 26 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.56230339 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54675232 |
| 28 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.52198790 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49067282 |
| 30 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.49029021 |
| 31 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.48262633 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47911609 |
| 33 | SA1_27219007_Chip-Seq_Bcells_Human | 1.43648127 |
| 34 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41492544 |
| 35 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.40202190 |
| 36 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.37340401 |
| 37 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.37340401 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.35606798 |
| 39 | MAF_26560356_Chip-Seq_TH1_Human | 1.33955109 |
| 40 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.33800956 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32626956 |
| 42 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.32625491 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31938339 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.29377442 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25384437 |
| 46 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22511633 |
| 47 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.21205319 |
| 48 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.19954908 |
| 49 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.18167386 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17987798 |
| 51 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17395690 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.17235894 |
| 53 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17031361 |
| 54 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15631564 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.14965005 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12901916 |
| 57 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.12862910 |
| 58 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11993222 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.11606300 |
| 60 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11601965 |
| 61 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09690770 |
| 62 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09419132 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07264488 |
| 64 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.07173968 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.05521513 |
| 66 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05467116 |
| 67 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.04834451 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.04448456 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04002253 |
| 70 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.03719845 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02851593 |
| 72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02533012 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01759384 |
| 74 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00542704 |
| 75 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00290984 |
| 76 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98953965 |
| 77 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95897820 |
| 78 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95797354 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95795488 |
| 80 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92304132 |
| 81 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91758325 |
| 82 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88079793 |
| 83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.86145649 |
| 84 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.86134691 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85542082 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.85279970 |
| 87 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84885086 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84594889 |
| 89 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79179175 |
| 90 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.77804282 |
| 91 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76229109 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76089360 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74665453 |
| 94 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.73422866 |
| 95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72252099 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72114937 |
| 97 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71566133 |
| 98 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.71103806 |
| 99 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70874194 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.70354779 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.69111919 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.68635424 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.68635424 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67715649 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67303922 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66133846 |
| 107 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.66128775 |
| 108 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.64906064 |
| 109 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.64756005 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.64550541 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.63854629 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.63742663 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.62834901 |
| 114 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.62585244 |
| 115 | CBP_21632823_ChIP-Seq_H3396_Human | 0.61611185 |
| 116 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.60940867 |
| 117 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.60855437 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60519513 |
| 119 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.60181305 |
| 120 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.59615036 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.59032962 |
| 122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.58876828 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.57896385 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.57736944 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.56269456 |
| 126 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.55612546 |
| 127 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.55102994 |
| 128 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.54870267 |
| 129 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.54055791 |
| 130 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53078281 |
| 131 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.52767170 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.52719419 |
| 133 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.52488309 |
| 134 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52233090 |
| 135 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.52137678 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.52086545 |
| 137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.51908714 |
| 138 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51772131 |
| 139 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51583091 |
| 140 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.51474804 |
| 141 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50426007 |
| 142 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.50015831 |
| 143 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.49985294 |
| 144 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.49247023 |
| 145 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.49234168 |
| 146 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.47999032 |
| 147 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47842024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.23434992 |
| 2 | MP0005360_urolithiasis | 5.63368764 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.08121153 |
| 4 | MP0005365_abnormal_bile_salt | 4.80029003 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.89218186 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.82295785 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.65584835 |
| 8 | MP0003646_muscle_fatigue | 3.32355770 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.98513023 |
| 10 | MP0003252_abnormal_bile_duct | 2.91901447 |
| 11 | MP0004130_abnormal_muscle_cell | 2.63843691 |
| 12 | MP0005083_abnormal_biliary_tract | 2.55333903 |
| 13 | MP0000751_myopathy | 2.51844912 |
| 14 | MP0005332_abnormal_amino_acid | 2.51619415 |
| 15 | MP0003195_calcinosis | 2.46922130 |
| 16 | MP0009840_abnormal_foam_cell | 2.46581464 |
| 17 | MP0000749_muscle_degeneration | 2.22793807 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.16474548 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.12260126 |
| 20 | MP0004036_abnormal_muscle_relaxation | 2.06924029 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.03934237 |
| 22 | MP0005330_cardiomyopathy | 2.00942982 |
| 23 | MP0004084_abnormal_cardiac_muscle | 1.91099966 |
| 24 | MP0005670_abnormal_white_adipose | 1.87319481 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.83281853 |
| 26 | MP0000609_abnormal_liver_physiology | 1.77811655 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.77573648 |
| 28 | MP0004215_abnormal_myocardial_fiber | 1.74672778 |
| 29 | MP0004510_myositis | 1.70092593 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.67308880 |
| 31 | MP0000733_abnormal_muscle_development | 1.67129756 |
| 32 | MP0004087_abnormal_muscle_fiber | 1.63626480 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.59262855 |
| 34 | MP0002269_muscular_atrophy | 1.54705236 |
| 35 | MP0002971_abnormal_brown_adipose | 1.49255685 |
| 36 | MP0000747_muscle_weakness | 1.48873265 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.47751937 |
| 38 | MP0003868_abnormal_feces_composition | 1.43020670 |
| 39 | MP0005451_abnormal_body_composition | 1.41319016 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.41114946 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.40246687 |
| 42 | MP0004019_abnormal_vitamin_homeostasis | 1.36472946 |
| 43 | MP0002106_abnormal_muscle_physiology | 1.34474244 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.34441914 |
| 45 | MP0001764_abnormal_homeostasis | 1.27999505 |
| 46 | MP0002972_abnormal_cardiac_muscle | 1.25590536 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.19456345 |
| 48 | MP0001544_abnormal_cardiovascular_syste | 1.19055553 |
| 49 | MP0005385_cardiovascular_system_phenoty | 1.19055553 |
| 50 | MP0009643_abnormal_urine_homeostasis | 1.18956590 |
| 51 | MP0004185_abnormal_adipocyte_glucose | 1.16191549 |
| 52 | MP0000759_abnormal_skeletal_muscle | 1.14921039 |
| 53 | MP0005535_abnormal_body_temperature | 1.14189116 |
| 54 | MP0010630_abnormal_cardiac_muscle | 1.13397127 |
| 55 | MP0000750_abnormal_muscle_regeneration | 1.13309749 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 1.13028032 |
| 57 | MP0006138_congestive_heart_failure | 1.13009598 |
| 58 | MP0008775_abnormal_heart_ventricle | 1.07610844 |
| 59 | MP0010368_abnormal_lymphatic_system | 1.06705859 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.06705728 |
| 61 | MP0005369_muscle_phenotype | 1.06514526 |
| 62 | MP0003828_pulmonary_edema | 1.06143895 |
| 63 | MP0005266_abnormal_metabolism | 1.05630040 |
| 64 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00687699 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.00158793 |
| 66 | MP0003186_abnormal_redox_activity | 0.99816766 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 0.98621262 |
| 68 | MP0005334_abnormal_fat_pad | 0.98161317 |
| 69 | MP0003137_abnormal_impulse_conducting | 0.97618567 |
| 70 | MP0005375_adipose_tissue_phenotype | 0.97382941 |
| 71 | MP0009697_abnormal_copulation | 0.96514247 |
| 72 | MP0004484_altered_response_of | 0.89830954 |
| 73 | MP0004043_abnormal_pH_regulation | 0.88794157 |
| 74 | MP0000598_abnormal_liver_morphology | 0.86464416 |
| 75 | MP0003011_delayed_dark_adaptation | 0.83011926 |
| 76 | MP0005376_homeostasis/metabolism_phenot | 0.77804688 |
| 77 | MP0000230_abnormal_systemic_arterial | 0.77629156 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.77317308 |
| 79 | MP0009642_abnormal_blood_homeostasis | 0.76912840 |
| 80 | MP0009763_increased_sensitivity_to | 0.75888147 |
| 81 | MP0004085_abnormal_heartbeat | 0.74784264 |
| 82 | MP0005448_abnormal_energy_balance | 0.72518875 |
| 83 | MP0003879_abnormal_hair_cell | 0.69609475 |
| 84 | MP0004270_analgesia | 0.68397171 |
| 85 | MP0004147_increased_porphyrin_level | 0.68120138 |
| 86 | MP0002822_catalepsy | 0.66926130 |
| 87 | MP0003045_fibrosis | 0.66134310 |
| 88 | MP0009764_decreased_sensitivity_to | 0.64473447 |
| 89 | MP0005647_abnormal_sex_gland | 0.64188674 |
| 90 | MP0008469_abnormal_protein_level | 0.63393031 |
| 91 | MP0000604_amyloidosis | 0.62712287 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 0.62690386 |
| 93 | MP0000266_abnormal_heart_morphology | 0.60482646 |
| 94 | MP0001661_extended_life_span | 0.60343057 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.57875265 |
| 96 | MP0004233_abnormal_muscle_weight | 0.57062906 |
| 97 | MP0009115_abnormal_fat_cell | 0.56969399 |
| 98 | MP0002970_abnormal_white_adipose | 0.55829675 |
| 99 | MP0005452_abnormal_adipose_tissue | 0.53704332 |
| 100 | MP0003329_amyloid_beta_deposits | 0.53446721 |
| 101 | MP0000343_altered_response_to | 0.53339574 |
| 102 | MP0005165_increased_susceptibility_to | 0.53245693 |
| 103 | MP0002127_abnormal_cardiovascular_syste | 0.52792222 |
| 104 | MP0002638_abnormal_pupillary_reflex | 0.51286466 |
| 105 | MP0008874_decreased_physiological_sensi | 0.51264445 |
| 106 | MP0005058_abnormal_lysosome_morphology | 0.51180259 |
| 107 | MP0003953_abnormal_hormone_level | 0.51116815 |
| 108 | MP0001756_abnormal_urination | 0.51064016 |
| 109 | MP0000372_irregular_coat_pigmentation | 0.49023732 |
| 110 | MP0001853_heart_inflammation | 0.45819872 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.45357212 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.44603426 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.43769026 |
| 114 | MP0003959_abnormal_lean_body | 0.42607904 |
| 115 | MP0005166_decreased_susceptibility_to | 0.41597197 |
| 116 | MP0008004_abnormal_stomach_pH | 0.40912685 |
| 117 | MP0002128_abnormal_blood_circulation | 0.38648874 |
| 118 | MP0008569_lethality_at_weaning | 0.38480296 |
| 119 | MP0003948_abnormal_gas_homeostasis | 0.35721830 |
| 120 | MP0008260_abnormal_autophagy | 0.33642571 |
| 121 | MP0003950_abnormal_plasma_membrane | 0.31511334 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.31050178 |
| 123 | MP0002009_preneoplasia | 0.30326216 |
| 124 | MP0009780_abnormal_chondrocyte_physiolo | 0.29960732 |
| 125 | MP0003075_altered_response_to | 0.29955887 |
| 126 | MP0009278_abnormal_bone_marrow | 0.28507278 |
| 127 | MP0009672_abnormal_birth_weight | 0.25206294 |
| 128 | MP0002132_abnormal_respiratory_system | 0.24772554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myopathic facies (HP:0002058) | 5.57459438 |
| 2 | Distal arthrogryposis (HP:0005684) | 5.26946291 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.00849932 |
| 4 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.88099780 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.83970456 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.71933010 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.68311665 |
| 8 | Exercise-induced myalgia (HP:0003738) | 4.50507612 |
| 9 | Ketosis (HP:0001946) | 4.44671589 |
| 10 | Myoglobinuria (HP:0002913) | 4.40086704 |
| 11 | Hyperglycinuria (HP:0003108) | 4.39401721 |
| 12 | Neck muscle weakness (HP:0000467) | 4.38638946 |
| 13 | Round ear (HP:0100830) | 4.37709922 |
| 14 | Hyperammonemia (HP:0001987) | 4.36540587 |
| 15 | Xanthomatosis (HP:0000991) | 4.32833193 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.30409291 |
| 17 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.26874441 |
| 18 | Rimmed vacuoles (HP:0003805) | 4.18431708 |
| 19 | Ketoacidosis (HP:0001993) | 4.10030980 |
| 20 | Ulnar deviation of the wrist (HP:0003049) | 4.04967245 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.02878063 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 4.02878063 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.98713886 |
| 24 | Hypobetalipoproteinemia (HP:0003563) | 3.93428944 |
| 25 | Hyperlipoproteinemia (HP:0010980) | 3.91790916 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.91325256 |
| 27 | Hyperglycinemia (HP:0002154) | 3.87988299 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 3.80949795 |
| 29 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.80949795 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 3.69452741 |
| 31 | Exercise-induced muscle cramps (HP:0003710) | 3.63250853 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.61542663 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.55856101 |
| 34 | Rhabdomyolysis (HP:0003201) | 3.54421815 |
| 35 | Bundle branch block (HP:0011710) | 3.50565301 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 3.47658718 |
| 37 | Hypolipoproteinemia (HP:0010981) | 3.47082802 |
| 38 | Calcaneovalgus deformity (HP:0001848) | 3.41490146 |
| 39 | Calf muscle hypertrophy (HP:0008981) | 3.39911588 |
| 40 | Frequent falls (HP:0002359) | 3.37372452 |
| 41 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.35847204 |
| 42 | Complement deficiency (HP:0004431) | 3.35814634 |
| 43 | Areflexia of lower limbs (HP:0002522) | 3.35072057 |
| 44 | EMG: neuropathic changes (HP:0003445) | 3.23886509 |
| 45 | Sudden death (HP:0001699) | 3.23695717 |
| 46 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.21551461 |
| 47 | Cerebral edema (HP:0002181) | 3.20190143 |
| 48 | Hepatic necrosis (HP:0002605) | 3.19561622 |
| 49 | Muscle fiber inclusion bodies (HP:0100299) | 3.17517347 |
| 50 | Generalized aminoaciduria (HP:0002909) | 3.15656696 |
| 51 | Absent phalangeal crease (HP:0006109) | 3.03052114 |
| 52 | Epidermoid cyst (HP:0200040) | 2.98856794 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.97324302 |
| 54 | Deformed tarsal bones (HP:0008119) | 2.96191606 |
| 55 | Metabolic acidosis (HP:0001942) | 2.95529606 |
| 56 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.95275683 |
| 57 | Generalized muscle weakness (HP:0003324) | 2.95259108 |
| 58 | Hyporeflexia of lower limbs (HP:0002600) | 2.92695191 |
| 59 | Malignant hyperthermia (HP:0002047) | 2.90996809 |
| 60 | Joint hemorrhage (HP:0005261) | 2.90725524 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.87996790 |
| 62 | Lethargy (HP:0001254) | 2.84274333 |
| 63 | Muscle fiber splitting (HP:0003555) | 2.84038113 |
| 64 | Abnormality of serum amino acid levels (HP:0003112) | 2.81204419 |
| 65 | Progressive muscle weakness (HP:0003323) | 2.73909471 |
| 66 | Ventricular tachycardia (HP:0004756) | 2.72073680 |
| 67 | Bulbar palsy (HP:0001283) | 2.71296951 |
| 68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70071463 |
| 69 | Distal lower limb amyotrophy (HP:0008944) | 2.67724295 |
| 70 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.66869195 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.66853877 |
| 72 | Nemaline bodies (HP:0003798) | 2.66401424 |
| 73 | Fat malabsorption (HP:0002630) | 2.60962914 |
| 74 | Muscle stiffness (HP:0003552) | 2.55201082 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.54616237 |
| 76 | Gout (HP:0001997) | 2.54309991 |
| 77 | Acute encephalopathy (HP:0006846) | 2.53187688 |
| 78 | Difficulty running (HP:0009046) | 2.50668616 |
| 79 | Cholelithiasis (HP:0001081) | 2.49315025 |
| 80 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.49179756 |
| 81 | Palpitations (HP:0001962) | 2.48789806 |
| 82 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.48215532 |
| 83 | Asymmetric septal hypertrophy (HP:0001670) | 2.48042739 |
| 84 | Hyperbilirubinemia (HP:0002904) | 2.47593196 |
| 85 | Abnormal finger flexion creases (HP:0006143) | 2.46428607 |
| 86 | Delayed CNS myelination (HP:0002188) | 2.45934428 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 2.42248990 |
| 88 | Increased connective tissue (HP:0009025) | 2.40438307 |
| 89 | Abnormality of the calf musculature (HP:0001430) | 2.39585037 |
| 90 | Type 1 muscle fiber predominance (HP:0003803) | 2.39257510 |
| 91 | Vomiting (HP:0002013) | 2.38114523 |
| 92 | Abnormality of purine metabolism (HP:0004352) | 2.38050267 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.36918165 |
| 94 | Hypercholesterolemia (HP:0003124) | 2.36615795 |
| 95 | Renal cortical cysts (HP:0000803) | 2.33965979 |
| 96 | Skin nodule (HP:0200036) | 2.33351424 |
| 97 | EMG: myopathic abnormalities (HP:0003458) | 2.33128969 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 2.31795589 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 2.30885395 |
| 100 | Proximal tubulopathy (HP:0000114) | 2.30362916 |
| 101 | Weak cry (HP:0001612) | 2.29063890 |
| 102 | Abnormality of complement system (HP:0005339) | 2.27840979 |
| 103 | Lipoatrophy (HP:0100578) | 2.25249979 |
| 104 | * Increased muscle lipid content (HP:0009058) | 2.24728591 |
| 105 | Hyperkalemia (HP:0002153) | 2.24014166 |
| 106 | Hypoglycemic seizures (HP:0002173) | 2.23266171 |
| 107 | Abnormality of the foot musculature (HP:0001436) | 2.23163863 |
| 108 | Dilated cardiomyopathy (HP:0001644) | 2.21079125 |
| 109 | Atrioventricular block (HP:0001678) | 2.20482901 |
| 110 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19309292 |
| 111 | Gowers sign (HP:0003391) | 2.18762977 |
| 112 | Late onset (HP:0003584) | 2.18252725 |
| 113 | Scapular winging (HP:0003691) | 2.17800424 |
| 114 | Ragged-red muscle fibers (HP:0003200) | 2.15404802 |
| 115 | * Lactic acidosis (HP:0003128) | 2.12331861 |
| 116 | Ventricular arrhythmia (HP:0004308) | 2.11444361 |
| 117 | Nausea (HP:0002018) | 2.10841721 |
| 118 | Conjugated hyperbilirubinemia (HP:0002908) | 2.09682260 |
| 119 | Difficulty climbing stairs (HP:0003551) | 2.09379162 |
| 120 | Fetal akinesia sequence (HP:0001989) | 2.07163519 |
| 121 | Foot dorsiflexor weakness (HP:0009027) | 2.06573360 |
| 122 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.05071476 |
| 123 | Hyperuricemia (HP:0002149) | 2.04365284 |
| 124 | Increased purine levels (HP:0004368) | 2.04365284 |
| 125 | Neonatal onset (HP:0003623) | 2.03203450 |
| 126 | Limb-girdle muscle atrophy (HP:0003797) | 2.00363863 |
| 127 | Hyperglycemia (HP:0003074) | 2.00325643 |
| 128 | Slender build (HP:0001533) | 2.00021041 |
| 129 | Ventricular fibrillation (HP:0001663) | 1.99296639 |
| 130 | Muscular dystrophy (HP:0003560) | 1.98591019 |
| 131 | Heart block (HP:0012722) | 1.98368523 |
| 132 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.95657805 |
| 133 | Subaortic stenosis (HP:0001682) | 1.95657805 |
| 134 | Oligomenorrhea (HP:0000876) | 1.94909516 |
| 135 | Abnormality of the calcaneus (HP:0008364) | 1.93455315 |
| 136 | Myotonia (HP:0002486) | 1.92917600 |
| 137 | Methylmalonic aciduria (HP:0012120) | 1.92793914 |
| 138 | Waddling gait (HP:0002515) | 1.92722277 |
| 139 | Abnormality of urine glucose concentration (HP:0011016) | 1.91486734 |
| 140 | Glycosuria (HP:0003076) | 1.91486734 |
| 141 | Atrial fibrillation (HP:0005110) | 1.90732434 |
| 142 | Fatigable weakness (HP:0003473) | 1.87016920 |
| 143 | Abnormality of the neuromuscular junction (HP:0003398) | 1.87016920 |
| 144 | Lower limb amyotrophy (HP:0007210) | 1.85691061 |
| 145 | Spinal rigidity (HP:0003306) | 1.83414604 |
| 146 | Paralysis (HP:0003470) | 1.83341948 |
| 147 | Proximal amyotrophy (HP:0007126) | 1.79961084 |
| 148 | * Exercise intolerance (HP:0003546) | 1.76035271 |
| 149 | Hip contracture (HP:0003273) | 1.75962860 |
| 150 | Facial diplegia (HP:0001349) | 1.71559974 |
| 151 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.70287531 |
| 152 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.67470953 |
| 153 | Syncope (HP:0001279) | 1.54607661 |
| 154 | Metatarsus adductus (HP:0001840) | 1.50589395 |
| 155 | Nonprogressive disorder (HP:0003680) | 1.49312095 |
| 156 | Primary atrial arrhythmia (HP:0001692) | 1.43746939 |
| 157 | Cerebral palsy (HP:0100021) | 1.42292249 |
| 158 | Supraventricular tachycardia (HP:0004755) | 1.41551276 |
| 159 | Easy fatigability (HP:0003388) | 1.39360152 |
| 160 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.38625096 |
| 161 | Long clavicles (HP:0000890) | 1.36448310 |
| 162 | Steppage gait (HP:0003376) | 1.36267086 |
| 163 | Dysmetric saccades (HP:0000641) | 1.35680058 |
| 164 | Supraventricular arrhythmia (HP:0005115) | 1.35597887 |
| 165 | Prolonged QT interval (HP:0001657) | 1.34390486 |
| 166 | Type 2 muscle fiber atrophy (HP:0003554) | 1.34073143 |
| 167 | Muscle fiber atrophy (HP:0100295) | 1.32801624 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.26139541 |
| 2 | OBSCN | 4.63721568 |
| 3 | TTN | 3.99479499 |
| 4 | TRIB3 | 3.13712159 |
| 5 | PDK4 | 3.02193947 |
| 6 | PDK3 | 3.02193947 |
| 7 | PHKG1 | 2.82690358 |
| 8 | PHKG2 | 2.82690358 |
| 9 | PKN2 | 2.79474290 |
| 10 | SIK1 | 2.53730962 |
| 11 | PINK1 | 2.39013724 |
| 12 | ERN1 | 2.27170086 |
| 13 | PIK3CG | 2.25696948 |
| 14 | INSRR | 2.21190259 |
| 15 | FGFR4 | 2.19468625 |
| 16 | TIE1 | 2.02227161 |
| 17 | EEF2K | 1.98900780 |
| 18 | MAP2K3 | 1.98111872 |
| 19 | PDK2 | 1.81457224 |
| 20 | MAP3K7 | 1.81105096 |
| 21 | MAP2K4 | 1.68894266 |
| 22 | LMTK2 | 1.61133969 |
| 23 | MYLK | 1.57533757 |
| 24 | PIK3CA | 1.56913422 |
| 25 | FLT3 | 1.56148273 |
| 26 | MUSK | 1.53232200 |
| 27 | MAPK12 | 1.27259243 |
| 28 | PRKAA2 | 1.26715363 |
| 29 | NEK1 | 1.18288052 |
| 30 | TRPM7 | 1.15285804 |
| 31 | PRPF4B | 1.11656884 |
| 32 | MAPK11 | 1.11244625 |
| 33 | MAP2K6 | 1.07075750 |
| 34 | TAOK3 | 1.07041557 |
| 35 | DMPK | 0.98821209 |
| 36 | MAP3K13 | 0.93468601 |
| 37 | CCNB1 | 0.93091367 |
| 38 | PRKAA1 | 0.92970321 |
| 39 | PTK6 | 0.88565622 |
| 40 | TGFBR2 | 0.85677908 |
| 41 | NEK9 | 0.85063661 |
| 42 | MST1R | 0.78286195 |
| 43 | EPHB1 | 0.75394429 |
| 44 | KDR | 0.74943190 |
| 45 | MAP3K3 | 0.74075152 |
| 46 | PRKD1 | 0.73383779 |
| 47 | RIPK1 | 0.73268232 |
| 48 | TYK2 | 0.71883901 |
| 49 | PDPK1 | 0.69705212 |
| 50 | MAP3K6 | 0.68751576 |
| 51 | KSR2 | 0.66402365 |
| 52 | CAMK1D | 0.65704079 |
| 53 | CAMK2G | 0.65394660 |
| 54 | ERBB4 | 0.63422508 |
| 55 | PKN1 | 0.62358999 |
| 56 | STK38L | 0.62075995 |
| 57 | NME1 | 0.62004940 |
| 58 | TNK2 | 0.61734701 |
| 59 | JAK2 | 0.61071904 |
| 60 | WNK4 | 0.60914100 |
| 61 | MAPK4 | 0.59586953 |
| 62 | PAK3 | 0.58457031 |
| 63 | PRKACG | 0.57948226 |
| 64 | PDK1 | 0.57430462 |
| 65 | GRK7 | 0.56223119 |
| 66 | CAMK2D | 0.55780232 |
| 67 | MAP3K5 | 0.55733464 |
| 68 | ABL2 | 0.55372612 |
| 69 | TBK1 | 0.54531746 |
| 70 | MAP3K11 | 0.53782893 |
| 71 | ZAP70 | 0.53403148 |
| 72 | JAK1 | 0.52838563 |
| 73 | MARK2 | 0.52014394 |
| 74 | TAOK2 | 0.51494609 |
| 75 | STK24 | 0.50286497 |
| 76 | MAPKAPK3 | 0.49278332 |
| 77 | MAP2K1 | 0.46021723 |
| 78 | MAPK7 | 0.45040417 |
| 79 | DAPK2 | 0.44439401 |
| 80 | RPS6KC1 | 0.44351972 |
| 81 | RPS6KL1 | 0.44351972 |
| 82 | MOS | 0.43118096 |
| 83 | CAMK4 | 0.42535531 |
| 84 | CAMK1G | 0.40596229 |
| 85 | RPS6KA6 | 0.40579543 |
| 86 | PRKG1 | 0.39960265 |
| 87 | RET | 0.39358777 |
| 88 | SMG1 | 0.37786478 |
| 89 | MAP3K1 | 0.37008591 |
| 90 | IRAK3 | 0.36540089 |
| 91 | SGK3 | 0.36071608 |
| 92 | PRKACA | 0.34989625 |
| 93 | PRKACB | 0.34411607 |
| 94 | MTOR | 0.32665474 |
| 95 | ICK | 0.32544607 |
| 96 | LATS1 | 0.31917525 |
| 97 | RPS6KA1 | 0.31598930 |
| 98 | ILK | 0.31231579 |
| 99 | RPS6KB2 | 0.30908702 |
| 100 | SGK1 | 0.30886136 |
| 101 | FGFR2 | 0.30185349 |
| 102 | TAOK1 | 0.29616134 |
| 103 | RPS6KB1 | 0.28751909 |
| 104 | CAMK1 | 0.28508778 |
| 105 | MAPK15 | 0.28300601 |
| 106 | RPS6KA3 | 0.28150661 |
| 107 | MARK3 | 0.28077524 |
| 108 | SGK2 | 0.27547323 |
| 109 | MAP4K1 | 0.27029238 |
| 110 | AKT2 | 0.26702428 |
| 111 | EPHA3 | 0.26645237 |
| 112 | LIMK1 | 0.26628738 |
| 113 | FES | 0.26298920 |
| 114 | RAF1 | 0.26274297 |
| 115 | AKT3 | 0.25897057 |
| 116 | CAMK2A | 0.25804131 |
| 117 | PRKCQ | 0.25668689 |
| 118 | MAPK10 | 0.25358493 |
| 119 | GSK3A | 0.24046062 |
| 120 | ROCK1 | 0.23537216 |
| 121 | CAMK2B | 0.23295830 |
| 122 | MAPK3 | 0.22978332 |
| 123 | SYK | 0.22934041 |
| 124 | STK38 | 0.22047467 |
| 125 | DYRK1B | 0.21342243 |
| 126 | PRKCZ | 0.21197637 |
| 127 | MET | 0.21043281 |
| 128 | PRKCH | 0.20603576 |
| 129 | MARK1 | 0.20516071 |
| 130 | DAPK3 | 0.20207709 |
| 131 | PDGFRA | 0.19999086 |
| 132 | KIT | 0.19827871 |
| 133 | FGFR3 | 0.19811250 |
| 134 | MAP2K2 | 0.18707072 |
| 135 | FRK | 0.18150830 |
| 136 | STK11 | 0.17992702 |
| 137 | HCK | 0.17448991 |
| 138 | ARAF | 0.17439365 |
| 139 | CDC42BPA | 0.16010096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47390906 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44551841 |
| 3 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.34365738 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.26390319 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.17686648 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.92825131 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.91685239 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90403417 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79603337 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.57571215 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54146718 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52962097 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51879126 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.44534111 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32045314 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06130123 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.01228612 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 1.99797929 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.97001214 |
| 20 | Carbon metabolism_Homo sapiens_hsa01200 | 1.93475912 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89014606 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87421891 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79944298 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.79835131 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.71201356 |
| 26 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58796571 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54471481 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.47587070 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45222118 |
| 30 | Histidine metabolism_Homo sapiens_hsa00340 | 1.40047530 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39745373 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36491396 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36317526 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35610956 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29703458 |
| 36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.26516271 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20700282 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20652815 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.20480924 |
| 40 | Bile secretion_Homo sapiens_hsa04976 | 1.20333433 |
| 41 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19964747 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18335515 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16225888 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10643751 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10012408 |
| 46 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06235675 |
| 47 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05042611 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01994571 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96598774 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.95991614 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.90909316 |
| 52 | Lysine degradation_Homo sapiens_hsa00310 | 0.90860712 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.89052499 |
| 54 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.88143325 |
| 55 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86931476 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82585444 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.81652113 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80354664 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.78713762 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78612498 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78287885 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78190096 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.76355258 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.71945270 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71505024 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70288484 |
| 67 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68658307 |
| 68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.67300526 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.63740077 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63437135 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60184101 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.60093340 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57480801 |
| 74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.55586598 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54746561 |
| 76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.53815252 |
| 77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53314956 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52653777 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.52402942 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52052982 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51943874 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47412492 |
| 83 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46321930 |
| 84 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44332591 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43779752 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42330187 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40885546 |
| 88 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39778367 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39420723 |
| 90 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38450825 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38175739 |
| 92 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38092380 |
| 93 | Platelet activation_Homo sapiens_hsa04611 | 0.36646233 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35271940 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33255887 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32226211 |
| 97 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30352971 |
| 98 | Huntingtons disease_Homo sapiens_hsa05016 | 0.26941076 |
| 99 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25011974 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22488371 |
| 101 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20862398 |
| 102 | Insulin secretion_Homo sapiens_hsa04911 | 0.17473458 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16637659 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16526440 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.16443210 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.16369605 |
| 107 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16104977 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.13022865 |
| 109 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12309931 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.11720888 |
| 111 | Purine metabolism_Homo sapiens_hsa00230 | 0.11626994 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.11533083 |
| 113 | Salivary secretion_Homo sapiens_hsa04970 | 0.09390136 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.06771327 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04945374 |
| 116 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.02021949 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.00614451 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1642504 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.1564169 |
| 120 | Calcium signaling pathway_Homo sapiens_hsa04020 | -0.1478068 |
| 121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0706055 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0553034 |
| 123 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0534473 |
| 124 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0383328 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.0373248 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0345322 |

